TCON

TRACON Pharmaceuticals, Inc. Common Stock
TCON

Overview Fund Activity
Delisted

TCON was delisted on the 27th of June, 2024.

Back to rankings

25 hedge funds and large institutions have $11.6M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
25
Holders Change
+1
Holders Change %
+4.17%
% of All Funds
0.54%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
5
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$822K
2
TI
2
Telemetry Investments
New York
$468K
3
WS
3
Wedbush Securities
California
$32K
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$66K
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$26K

Top Sellers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$598K
2
BlackRock
2
BlackRock
New York
$38K
3
RJA
3
Raymond James & Associates
Florida
$0
4
Jane Street
4
Jane Street
New York
$0
5
SBIA
5
Sheaff Brock Investment Advisors
Indiana
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Jane Street
26
Jane Street
New York
– -$23K -84 Closed
SBIA
27
Sheaff Brock Investment Advisors
Indiana
– -$17K -63 Closed
TRCT
28
Tower Research Capital (TRC)
New York
– -$4K -13 Closed
BAM
29
Bruderman Asset Management
New York
– -$3K -10 Closed
1
2